taxonomy (7)
protein (140)
source (29)
structure (23)
composition (1)
disease (10)
reference (26)
site (175)
peptide (165)
- Homo sapiens (Human)
- Bos taurus (Bovine)
- Hybrid - homo sapiens/mus musculus (Hybrid - human/mouse)
- Mus musculus (House mouse)
- Rattus norvegicus (Norway rat)
- Sus scrofa (Pig)
- Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Taxonomy
- Alpha-1-antichymotrypsin / Homo sapiens P01011
- Alpha-1-antitrypsin / Homo sapiens P01009
- Alpha-2-HS-glycoprotein / Homo sapiens P02765
- Alpha-2-macroglobulin receptor-associated protein / Homo sapiens P30533
- Anoctamin-6 / Homo sapiens Q4KMQ2
- Antithrombin-III / Homo sapiens P01008
- Apolipoprotein D / Homo sapiens P05090
- Basement membrane-specific heparan sulfate proteoglycan core protein / Homo sapiens P98160
- Beta-2-glycoprotein 1 / Homo sapiens P02749
- Biglycan / Homo sapiens P21810
- Calbindin / Homo sapiens P05937
- Carcinoembryonic antigen-related cell adhesion molecule 5 / Homo sapiens P06731
- CD276 antigen / Homo sapiens Q5ZPR3
- CD59 glycoprotein / Homo sapiens P13987
- Ceruloplasmin / Homo sapiens P00450
- CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 / Homo sapiens Q11201
- Coagulation factor XIII B chain / Homo sapiens P05160
- Collagen alpha-1(VI) chain / Homo sapiens P12109
- Collagen alpha-1(XII) chain / Homo sapiens Q99715
- Collagen alpha-2(VI) chain / Homo sapiens P12110
- Collagen alpha-3(VI) chain / Homo sapiens P12111
- Complement component C9 / Homo sapiens P02748
- Complement factor b / Homo sapiens P00751
- Complement factor h / Homo sapiens P08603
- Complement factor H-related protein 1 / Homo sapiens Q03591
- Decorin / Homo sapiens P07585
- Desmocollin-2 / Homo sapiens Q02487
- Dipeptidyl peptidase 1 / Homo sapiens P53634
- Disintegrin and metalloproteinase domain-containing protein 17 / Homo sapiens P78536
- DNA-dependent protein kinase catalytic subunit / Homo sapiens P78527
- Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B / Homo sapiens Q8TCJ2
- Fibrillin-1 / Homo sapiens P35555
- Fibrinogen beta chain / Homo sapiens P02675
- Fibrinogen gamma chain / Homo sapiens P02679
- Fibromodulin / Homo sapiens Q06828
- Fibronectin / Homo sapiens P02751
- Haptoglobin / Homo sapiens P00738
- Hemopexin / Homo sapiens P02790
- Histidine-rich glycoprotein / Homo sapiens P04196
- Hypoxia up-regulated protein 1 / Homo sapiens Q9Y4L1
- Immunoglobulin heavy constant alpha 1 / Homo sapiens P01876
- Immunoglobulin heavy constant alpha 2 / Homo sapiens P01877
- Immunoglobulin heavy constant gamma 1 / Homo sapiens P01857
- Immunoglobulin heavy constant mu / Homo sapiens P01871
- Immunoglobulin J chain / Homo sapiens P01591
- Integrin alpha-1 / Homo sapiens P56199
- Integrin alpha-2 / Homo sapiens P17301
- Integrin alpha-6 / Homo sapiens P23229
- Inter-alpha-trypsin inhibitor heavy chain H3 / Homo sapiens Q06033
- Interleukin-1 receptor accessory protein / Homo sapiens Q9NPH3
- Lactotransferrin / Homo sapiens P02788
- Laminin subunit alpha-4 / Homo sapiens Q16363
- Laminin subunit alpha-5 / Homo sapiens O15230
- Laminin subunit gamma-1 / Homo sapiens P11047
- Latent-transforming growth factor beta-binding protein 2 / Homo sapiens Q14767
- Lysosome membrane protein 2 / Homo sapiens Q14108
- Lysosome-associated membrane glycoprotein 1 / Homo sapiens P11279
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens P13473
- Mannan-binding lectin serine protease 1 / Homo sapiens P48740
- Mimecan / Homo sapiens P20774
- Niemann-Pick C1 protein / Homo sapiens O15118
- Olfactomedin-like protein 3 / Homo sapiens Q9NRN5
- Peptidyl-prolyl cis-trans isomerase FKBP10 / Homo sapiens Q96AY3
- Periostin / Homo sapiens Q15063
- Plexin-B2 / Homo sapiens O15031
- Polymeric immunoglobulin receptor / Homo sapiens P01833
- Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 / Homo sapiens Q02809
- Prolactin-inducible protein / Homo sapiens P12273
- Prolargin / Homo sapiens P51888
- Prolow-density lipoprotein receptor-related protein 1 / Homo sapiens Q07954
- Prostaglandin-h2 d-isomerase / Homo sapiens P41222
- Protein AMBP / Homo sapiens P02760
- Protein disulfide-isomerase A2 / Homo sapiens Q13087
- Prothrombin / Homo sapiens P00734
- Reticulocalbin-1 / Homo sapiens Q15293
- Secretogranin-3 / Homo sapiens Q8WXD2
- Serotransferrin / Homo sapiens P02787
- Sparc / Homo sapiens P09486
- Tetraspanin-3 / Homo sapiens O60637
- Thrombospondin-1 / Homo sapiens P07996
- Thrombospondin-2 / Homo sapiens P35442
- Translocon-associated protein subunit alpha / Homo sapiens P43307
- Uromodulin / Homo sapiens P07911
- Vitronectin / Homo sapiens P04004
- Von willebrand factor / Homo sapiens P04275
- Zinc-alpha-2-glycoprotein / Homo sapiens P25311
- Collagen alpha-1(IV) chain / Bos taurus Q7SIB2
- Collagen alpha-2 (IV) chain / Bos taurus Q7SIB3
- Ribonuclease, brain / Bos taurus P39873
- Immunoglobulin gamma-2 (anti-nip antibody) / Hybrid - homo sapiens/mus musculus
- Immunoglobulin gamma-2b (anti-nip antibody) / Hybrid - homo sapiens/mus musculus
- Immunoglobulin gamma-3 (anti-nip antibody) / Hybrid - homo sapiens/mus musculus
- Immunoglobulin gamma-3b (anti-nip antibody) / Hybrid - homo sapiens/mus musculus
- Cadherin-10 / Mus musculus P70408
- Cadherin-13 / Mus musculus Q9WTR5
- Carbonic anhydrase-related protein 10 / Mus musculus P61215
- Carboxypeptidase D / Mus musculus O89001
- Carboxypeptidase M / Mus musculus Q80V42
- Cell adhesion molecule 4 / Mus musculus Q8R464
- Contactin-1 / Mus musculus P12960
- Dipeptidyl aminopeptidase-like protein 6 / Mus musculus Q9Z218
- Gamma-aminobutyric acid receptor subunit beta-2 / Mus musculus P63137
- Golgi apparatus protein 1 / Mus musculus Q61543
- Heparan sulfate 2-O-sulfotransferase 1 / Mus musculus Q8R3H7
- Immunoglobulin superfamily member 8 / Mus musculus Q8R366
- Integrin beta-2 / Mus musculus P11835
- Isoform 14 of Disintegrin and metalloproteinase domain-containing protein 22 / Mus musculus Q9R1V6-16
- Isoform 2 of Cell adhesion molecule 2 / Mus musculus Q8BLQ9-2
- Leukocyte surface antigen CD47 / Mus musculus Q61735
- Myelin-oligodendrocyte glycoprotein / Mus musculus Q61885
- Nectin-1 / Mus musculus Q9JKF6
- Neural cell adhesion molecule L1 / Mus musculus P11627
- Neurofascin / Mus musculus A0A087WPX3
- Neuroplastin / Mus musculus P97300
- Prolow-density lipoprotein receptor-related protein 1 / Mus musculus Q91ZX7
- Receptor-type tyrosine-protein phosphatase delta / Mus musculus Q64487
- Signal-regulatory protein alpha / Mus musculus P97797
- Sodium/potassium-transporting ATPase subunit beta-2 / Mus musculus P14231
- SPARC / Mus musculus P07214
- SPARC-like protein 1 / Mus musculus P70663
- Tetraspanin-2 / Mus musculus Q922J6
- Thy-1 membrane glycoprotein / Mus musculus P01831
- Uncharacterized protein / Mus musculus
- Uncharacterized protein / Mus musculus
- Uncharacterized protein / Mus musculus
- Uncharacterized protein / Mus musculus
- Uncharacterized protein / Mus musculus
- Uncharacterized protein / Mus musculus
- Uncharacterized protein from Ascitic fluid / Mus musculus
- Zinc transporter ZIP10 / Mus musculus Q6P5F6
- Uncharacterized protein / Rattus norvegicus
- Amiloride-sensitive amine oxidase / Sus scrofa Q9TRC7
- Coagulation factor VIII / Sus scrofa P12263
- Major seminal plasma glycoprotein psp-i / Sus scrofa P35495
- Major seminal plasma glycoprotein psp-ii / Sus scrofa P35496
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
- Recombinant Spike glycoprotein (FreeStyle 293-F) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
- Recombinant Spike glycoprotein (HEK293) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
Protein
- Ascitic fluid (UBERON_0007795) EL4 (CVCL_0255)
- Ascitic fluid (UBERON_0007795)
- Blood Plasma (UBERON_0001969)
- Blood Serum (UBERON_0001977)
- Brain (UBERON_0000955)
- Colon (UBERON_0001155)
- Glomerular Basement Membrane (UBERON_0005777)
- Kidney (UBERON_0002113)
- Liver (UBERON_0002107)
- Mammary Gland (UBERON_0001911)
- Milk (UBERON_0001913)
- Seminal Fluid (UBERON_0006530)
- Urine (UBERON_0001088)
- BTI-Tn-5B1-4 (CVCL_C190)
- BW5147 (CVCL_3896) T-Lymphocyte (CL_0000084)
- CHO (CVCL_0213)
- FreeStyle 293-F (CVCL_D603)
- HEK293 (CVCL_0045)
- J558L (CVCL_3949)
- LS174T (CVCL_1384)
- WEHI-231 (CVCL_0577) B-Lymphocyte (CL_0000236)
- Adipocytes (CL_0000136)
- Adipose-derived stem cells (ADSCs) (CL_0000136)
- B-Lymphocyte (CL_0000236)
- Differentiated Adipose-derived stem cells (dADSCs) (CL_0000136)
- EBV-transformed B-cell (CL_0000236)
- Erythrocyte (CL_0000232) Plasma Membrane (GO_0005886)
- T-Lymphocyte (CL_0000084)
- Plasma Membrane (GO_0005886)
Source
- Free / Lactose / [Gal(b1-3)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-6)][[Fuc(a1-2)]Gal(b1-4)GlcNAc(b1-3)]Gal(b1-4)Glc(b1-
- Free / Lactose / [Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-6)][Gal(b1-3)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-3)]Gal(b1-4)Glc(b1-
- Free / Lactose / [Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-6)][[Fuc(a1-2)]Gal(b1-4)GlcNAc(b1-3)]Gal(b1-4)Glc(b1-
- Free / Lactose / Structure 9159
- Free / Lactose / Structure 9160
- Free / Lactose / Structure 9206
- Free / Lactose / Structure 10860
- Free / Lactose / Structure 10867
- N-Linked / Complex / Fuc(a1-2)[Gal(a1-3)]Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Fuc(a1-2)[Gal(a1-3)]Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Structure 9601
- N-Linked / Complex / Structure 9677
- N-Linked / Hybrid / Structure 9381
- N-Linked / Hybrid / Structure 9910
- N-Linked / Hybrid / Structure 10008
- N-Linked / Hybrid / Structure 10289
- N-Linked / Hybrid / Structure 10422
- N-Linked / Hybrid / Structure 10428
- N-Linked / Hybrid / Structure 10537
Reported structure
- Hex:6 HexNAc:4 dHex:1 (avg mass : 1949.7927 )
Composition
- Cancer, breast (DOID:1612)
- Colon adenocarcinoma (DOID:234)
- Control/Healthy
- COVID-19 (DOID:0080600)
- Hyper IgE syndrome (HIES, p.Glu340del) (DOID:0080545)
- Hyper IgE syndrome (HIES, p.Leu83Ser) (DOID:0080545)
- Lymphoma, Lymphoblastic (DOID:0080147)
- Lymphoma, Thymic (DOID:10146)
- Myeloma (DOID:0070004)
- Prostate cancer (DOID:10283)
Disease
- Structural and functional characterization of SARS-CoV-2 RBD domains produced in mammalian cells (2021 - Christoph Gstöttner, Tao Zhang, Anja Resemann, Sophia Ruben, Stuart Pengelley, Detlev Suckau, Tim Welsink, Manfred Wuhrer, Elena DomÃnguez-Vega) / Status : Reviewed
- Carcinoembryonic antigen glycosylation (2021 - Kolarich D) / Status : Reviewed
- Bisecting GlcNAc Protein N-Glycosylation Is Characteristic of Human Adipogenesis. (2020 - Katherine Wongtrakul-Kish, Benjamin R Herbert, Nicolle H Packer) / Status : Reviewed
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020 - Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang) / Status : Reviewed
- Site-specific glycan analysis of the SARS-CoV-2 spike (2020 - Yasunori Watanabe, Joel D. Allen, Daniel Wrapp, Jason S. McLellan, Max Crispin) / Status : Unreviewed
- Identification of 22 N-glycosites on spike glycoprotein of SARS-CoV-2 and accessible surface glycopeptide motifs: Implications for vaccination and antibody therapeutics (2020 - Dapeng Zhou, Xiaoxu Tian, Ruibing Qi, Chao Peng, Wen Zhang) / Status : Reviewed
- Increasing the Coverage of a Mass Spectral Library of Milk Oligosaccharides Using a Hybrid-Search-Based Bootstrapping Method and Milks from a Wide Variety of Mammals (2020 - Concepcion Africano Remoroza, Yuxue Liang, Tytus D. Mak, Yuri Mirokhin, Sergey L. Sheetlin, Xiaoyu Yang, Joice V. San Andres, Michael L. Power, and Stephen E. Stein) / Status : Reviewed
- Quantitative Longitudinal Inventory of the N-Glycoproteome of Human Milk from a Single Donor Reveals the Highly Variable Repertoire and Dynamic Site-Specific Changes (2020 - Jing Zhu, Yu-Hsien Lin, Kelly A Dingess, Marko Mank, Bernd Stahl, Albert J R Heck) / Status : Reviewed
- Capturing site-specific heterogeneity with large-scale N-glycoproteome analysis (2019 - Nicholas M. Riley, Alexander S. Hebert, Michael S. Westphall & Joshua J. Coon ) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Human milk oligosaccharides as essential tools for basic and application studies on galectins (2018 - Tadasu Urashima, Jun Hirabayashi, Sachiko Sato, Akira Kobata) / Status : Reviewed
- Synthesis of Asymmetrical Multiantennary Human Milk Oligosaccharides (2017 - Anthony R Prudden, Lin Liu, Chantelle J Capicciotti, Margreet A Wolfert, Shuo Wang, Zhongwei Gao, Lu Meng, Kelley W Moremen, Geert-Jan Boons) / Status : Reviewed
- Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels, (2014 - Atfa Sassi, Sandra Lazaroski, Gang Wu, Stuart M. Haslam, Manfred Fliegauf, Fethi Mellouli, Turkan Patiroglu, Ekrem Unal, Mehmet Akif Ozdemir, Zineb Jouhadi, Khadija Khadir, Leila Ben-Khemis, Meriem Ben-Ali, Imen Ben-Mustapha, Lamia Borchani, Dietmar Pfeifer, Thilo Jakob, Monia Khemiri, A. Charlotta Asplund, Manuela O. Gustafsson, Karin E. Lundin, Elin Falk-Sörqvist, Lotte N. Moens, Hatice Eke Gungor, Karin R. Engelhardt, Magdalena Dziadzio, Hans Stauss, Bernhard Fleckenstein, Rebecca Meier, Khairunnadiya Prayitno, Andrea Maul-Pavicic, Sandra Schaffer, Mirzokhid Rakhmanov, Philipp Henneke, Helene Kraus, Hermann Eibel, Uwe Kölsch, Sellama Nadifi, Mats Nilsson, Mohamed Bejaoui, Alejandro A. Schäffer, C.I. Edvard Smith, Anne Dell, Mohamed-Ridha Barbouche, Bodo Grimbacher) / Status : Reviewed
- Efficient and accurate glycopeptide identification pipeline for high-throughput site-specific N-glycosylation analysis (2014 - Liu M, Zhang Y, Chen Y, Yan G, Shen C, Cao J, Zhou X, Liu X, Zhang L, Shen H, Lu H, He F, Yang P) / Status : Reviewed
- Development of an Annotated Library of Neutral Human Milk Oligosaccharides (2010 - Shuai Wu, Nannan Tao, J Bruce German, Rudolf Grimm, Carlito B Lebrilla) / Status : Reviewed
- N-linked oligosaccharide structures in the diamine oxidase from porcine kidney. (2000 - Huang Y, Mechref Y, Novotny M) / Status : Reviewed
- Structural characterization of the oligosaccharide chains of native and crystallized boar seminal plasma spermadhesin PSP-I and PSP-II glycoforms. (1999 - Nimtz M, Grabenhorst E, Conradt H, Sanz L, Calvete J) / Status : Reviewed
- Structural study of the sugar chains of porcine factor VIII--tissue- and species-specific glycosylation of factor VIII. (1993 - Hironaka T, Furukawa K, Esmon P, Yokota T, Brown J, Sawada S, Fournel M, Kato M, Minaga T, Kobata A) / Status : Reviewed
- Control of IgG/Fc glycosylation: a comparison of oligosaccharides from chimeric human/mouse and mouse subclass immunoglobulin Gs. (1993 - Lund J, Takahashi N, Nakagawa H, Goodall M, Bentley T, Hindley S, Tyler R, Jefferis R) / Status : Reviewed
- Structures of the asparagine-linked oligosaccharide chains of human von Willebrand factor. Occurrence of blood group A, B, and H(O) structures. (1992 - Matsui T, Titani K, Mizuochi T) / Status : Reviewed
- Bovine glomerular basement membrane. Location and structure of the asparagine-linked oligosaccharide units and their potential role in the assembly of the 7 S collagen IV tetramer. (1991 - Langeveld J, Noelken M, Hrd K, Todd P, Vliegenthart J, Rouse J, Hudson B) / Status : Reviewed
- Cell type and maturation stage-dependent polymorphism of N-linked oligosaccharides on murine lymphocytes and lymphoma cells. (1991 - Yoshida T, Takahashi N, Nakashima I) / Status : Reviewed
- The structure of the asparagine-linked sugar chains of bovine brain ribonuclease. (1990 - Katoh H, Ohgi K, Irie M, Endo T, Kobata A) / Status : Reviewed
- A protein structural change in aglycosylated IgG3 correlates with loss of huFc gamma R1 and huFc gamma R111 binding and/or activation. (1990 - Lund J, Tanaka T, Takahashi N, Sarmay G, Arata Y, Jefferis R) / Status : Reviewed
- The asparagine-linked sugar chains of the glycoproteins in rat erythrocyte plasma membrane--fractionation of oligosaccharides liberated by hydrazinolysis and structural studies of the neutral oligosaccharides. (1982 - Matsumoto A, Yoshima H, Maeda S, Shiraishi N, Kobata A) / Status : Reviewed
Reference
- Alpha-1-antichymotrypsin / Homo sapiens
- Alpha-1-antitrypsin / Homo sapiens
- Alpha-2-HS-glycoprotein / Homo sapiens
- Alpha-2-macroglobulin receptor-associated protein / Homo sapiens
- Anoctamin-6 / Homo sapiens
- Antithrombin-III / Homo sapiens
- Apolipoprotein D / Homo sapiens
- Basement membrane-specific heparan sulfate proteoglycan core protein / Homo sapiens
- Beta-2-glycoprotein 1 / Homo sapiens
- Biglycan / Homo sapiens
- Calbindin / Homo sapiens
-
Carcinoembryonic antigen-related cell adhesion molecule 5 / Homo sapiens
- Undefined site
- CD276 antigen / Homo sapiens
- CD59 glycoprotein / Homo sapiens
- Ceruloplasmin / Homo sapiens
- CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 / Homo sapiens
- Coagulation factor XIII B chain / Homo sapiens
- Collagen alpha-1(VI) chain / Homo sapiens
- Collagen alpha-1(XII) chain / Homo sapiens
- Collagen alpha-2(VI) chain / Homo sapiens
- Collagen alpha-3(VI) chain / Homo sapiens
- Complement component C9 / Homo sapiens
- Complement factor b / Homo sapiens
- Complement factor h / Homo sapiens
- Complement factor H-related protein 1 / Homo sapiens
- Decorin / Homo sapiens
- Desmocollin-2 / Homo sapiens
- Dipeptidyl peptidase 1 / Homo sapiens
- Disintegrin and metalloproteinase domain-containing protein 17 / Homo sapiens
- DNA-dependent protein kinase catalytic subunit / Homo sapiens
- Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B / Homo sapiens
- Fibrillin-1 / Homo sapiens
- Fibrinogen beta chain / Homo sapiens
- Fibrinogen gamma chain / Homo sapiens
- Fibromodulin / Homo sapiens
- Fibronectin / Homo sapiens
- Haptoglobin / Homo sapiens
- Hemopexin / Homo sapiens
- Histidine-rich glycoprotein / Homo sapiens
- Hypoxia up-regulated protein 1 / Homo sapiens
- Immunoglobulin heavy constant alpha 1 / Homo sapiens
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- Immunoglobulin heavy constant gamma 1 / Homo sapiens
- Immunoglobulin heavy constant mu / Homo sapiens
- Immunoglobulin J chain / Homo sapiens
- Integrin alpha-1 / Homo sapiens
- Integrin alpha-2 / Homo sapiens
- Integrin alpha-6 / Homo sapiens
- Inter-alpha-trypsin inhibitor heavy chain H3 / Homo sapiens
- Interleukin-1 receptor accessory protein / Homo sapiens
- Lactotransferrin / Homo sapiens
- Laminin subunit alpha-4 / Homo sapiens
- Laminin subunit alpha-5 / Homo sapiens
- Laminin subunit gamma-1 / Homo sapiens
- Latent-transforming growth factor beta-binding protein 2 / Homo sapiens
- Lysosome membrane protein 2 / Homo sapiens
- Lysosome-associated membrane glycoprotein 1 / Homo sapiens
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens
- Mannan-binding lectin serine protease 1 / Homo sapiens
- Mimecan / Homo sapiens
- Niemann-Pick C1 protein / Homo sapiens
- Olfactomedin-like protein 3 / Homo sapiens
- Peptidyl-prolyl cis-trans isomerase FKBP10 / Homo sapiens
- Periostin / Homo sapiens
- Plexin-B2 / Homo sapiens
- Polymeric immunoglobulin receptor / Homo sapiens
- Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 / Homo sapiens
- Prolactin-inducible protein / Homo sapiens
- Prolargin / Homo sapiens
- Prolow-density lipoprotein receptor-related protein 1 / Homo sapiens
- Prostaglandin-h2 d-isomerase / Homo sapiens
- Protein AMBP / Homo sapiens
- Protein disulfide-isomerase A2 / Homo sapiens
- Prothrombin / Homo sapiens
- Reticulocalbin-1 / Homo sapiens
- Secretogranin-3 / Homo sapiens
- Serotransferrin / Homo sapiens
- Sparc / Homo sapiens
- Tetraspanin-3 / Homo sapiens
- Thrombospondin-1 / Homo sapiens
- Thrombospondin-2 / Homo sapiens
- Translocon-associated protein subunit alpha / Homo sapiens
- Uromodulin / Homo sapiens
- Vitronectin / Homo sapiens
-
Von willebrand factor / Homo sapiens
- Undefined site
- Zinc-alpha-2-glycoprotein / Homo sapiens
-
Collagen alpha-1(IV) chain / Bos taurus
- Undefined site
-
Collagen alpha-2 (IV) chain / Bos taurus
- Undefined site
- Ribonuclease, brain / Bos taurus
-
Immunoglobulin gamma-2 (anti-nip antibody) / Hybrid - homo sapiens/mus musculus
- Undefined site
-
Immunoglobulin gamma-2b (anti-nip antibody) / Hybrid - homo sapiens/mus musculus
- Undefined site
-
Immunoglobulin gamma-3 (anti-nip antibody) / Hybrid - homo sapiens/mus musculus
- Undefined site
-
Immunoglobulin gamma-3b (anti-nip antibody) / Hybrid - homo sapiens/mus musculus
- Undefined site
- Cadherin-10 / Mus musculus
- Cadherin-13 / Mus musculus
- Carbonic anhydrase-related protein 10 / Mus musculus
- Carboxypeptidase D / Mus musculus
- Carboxypeptidase M / Mus musculus
- Cell adhesion molecule 4 / Mus musculus
- Contactin-1 / Mus musculus
- Dipeptidyl aminopeptidase-like protein 6 / Mus musculus
- Gamma-aminobutyric acid receptor subunit beta-2 / Mus musculus
- Golgi apparatus protein 1 / Mus musculus
- Heparan sulfate 2-O-sulfotransferase 1 / Mus musculus
- Immunoglobulin superfamily member 8 / Mus musculus
- Integrin beta-2 / Mus musculus
- Isoform 14 of Disintegrin and metalloproteinase domain-containing protein 22 / Mus musculus
- Isoform 2 of Cell adhesion molecule 2 / Mus musculus
- Leukocyte surface antigen CD47 / Mus musculus
- Myelin-oligodendrocyte glycoprotein / Mus musculus
- Nectin-1 / Mus musculus
- Neural cell adhesion molecule L1 / Mus musculus
- Neurofascin / Mus musculus
- Neuroplastin / Mus musculus
- Prolow-density lipoprotein receptor-related protein 1 / Mus musculus
- Receptor-type tyrosine-protein phosphatase delta / Mus musculus
- Signal-regulatory protein alpha / Mus musculus
- Sodium/potassium-transporting ATPase subunit beta-2 / Mus musculus
- SPARC / Mus musculus
- SPARC-like protein 1 / Mus musculus
- Tetraspanin-2 / Mus musculus
- Thy-1 membrane glycoprotein / Mus musculus
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein from Ascitic fluid / Mus musculus
- Undefined site
- Zinc transporter ZIP10 / Mus musculus
-
Uncharacterized protein / Rattus norvegicus
- Undefined site
-
Amiloride-sensitive amine oxidase / Sus scrofa
- Undefined site
-
Coagulation factor VIII / Sus scrofa
- Undefined site
- Major seminal plasma glycoprotein psp-i / Sus scrofa
- Major seminal plasma glycoprotein psp-ii / Sus scrofa
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (FreeStyle 293-F) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Reported glycosite
- LELNLTDSENATCLYAK (17aa)
- SVAQNYSSITHLHSIGK (17aa)
- VKGSQGQFPLTQNVTVVEGGTAILTCR (27aa)
- GSQGQFPLTQNVTVVEGGTAILTCR (25aa)
- TAVNCSSDFDACLITK (16aa)
- VVRPDSEIGERPPEDNQSFQYDHEAFIGK (29aa)
- ISPGKNATGMEVGWYR (16aa)
- FSNVTWF (7aa)
- CSDGWSFDATTLDDNGTMLFFK (22aa)
- CIQANYSIMENGK (13aa)
- QTLFFNGTR (9aa)
- SVVAPATDGGLNLTSTFLR (19aa)
- DLQSLEDILHQVENK (15aa)
- FNQTMQPIITAQNAIIEDDTYR (22aa)
- RANLTNFPENGTFVVNIAQLSQDDSGRY (28aa)
- TAFITNFTLTIDGVTYPGNVK (21aa)
- IRNVSDTTKR (10aa)
- IRNVSDTTK (9aa)
- ADGTVNQIEGEATPVNLTEPAK (22aa)
- TAIFPDIIAQGNASIR (16aa)
- LSYNVIPLNLTLDNR (15aa)
- TFYWDFYTNR (10aa)
- ADTHDEIIEGINFNITEIPEAQIHEGFQEIIR (32aa)
- YHVLHINTTK (10aa)
- DIVEYYNDSNGSHVIQGR (18aa)
- DAMVGNYTCEVTELSR (16aa)
- VCSNDNKTFDSSCHFFATK (19aa)
- VCSNDNK (7aa)
- LDKEHLVNISGGPMTYSHR (19aa)
- NTTYCSK (7aa)
- DEGDYFCELQVSGANPMSSNK (21aa)
- IVNNATNVVIK (11aa)
- TQSLLIVNNATNVVIK (16aa)
- VIDFNCTTSSVSSAIANTK (19aa)
- TINQSSDEIQISMGNAMFVK (20aa)
- FGCEIENNR (9aa)
- LSLHRPALEDLLLGSEANLTCTLTGLR (27aa)
- YPQDYQFYIQNFTAIPINTVVPPQR (25aa)
- ARGNGTLITFHSAFQCCGK (19aa)
- ACQFNR (6aa)
- VCQDCPIIAPINDTR (15aa)
- VCQDCPLLAPLNDTR (15aa)
- LNLTTDPK (8aa)
- IYIDHNNITR (10aa)
- NQSVPISCCR (10aa)
- GIPDQKVNFTCK (12aa)
- VNFTCK (6aa)
- NGSLFAFR (8aa)
- AALAAFNAQNNGSNFQLEEISR (22aa)
- YHYNGTIIDGTSFDTSYSK (19aa)
- ACNATNWIEYMFNK (14aa)
- KQIGLYPVLVIDSSGYVNPNYTGRI (25aa)
- QIGLYPVLVIDSSGYVNPNYTGR (23aa)
- SWPAVGNCSSAIR (13aa)
- SWPAVGNCSSAL (12aa)
- SLTFNETYQDISELVYGAK (19aa)
- NASNMEYR (8aa)
- KNASNMEYR (9aa)
- EQINITIDHR (10aa)
- LKGEAEYQEIRNPNGTVTVISR (22aa)
- NPNGTVTVISR (11aa)
- IADTNITSIPQGIPPSITEIHIDGNK (26aa)
- KLNNLTFLYLDHNALESVPLNLPESLR (27aa)
- NTTGFK (6aa)
- CNTAAPMWLNGTHPSSDEGIVSR (23aa)
- VVIHPNYSQVDIGIIK (16aa)
- FEDGVLDPDYPRNISDGFDGIPDNVDAALALPAHSYSGR (39aa)
- FHLANR (6aa)
- CNMINGTDGDSFHPIITK (18aa)
- YFYNGTSMACETFQYGGCMGNGNNFVTEK (29aa)
- IGNWSAMPSCK (11aa)
- IININPNK (8aa)
- VIDLWDLAQSANLTDK (16aa)
- MIENGSISFIPTIR (14aa)
- YIGNATAIFFIPDEGK (16aa)
- YLGNATAIFFLPDEGK (16aa)
- LNSSTIK (7aa)
- IITNNSQTPIISPQEVVSCSQYAQGCEGGFPYIIAGK (37aa)
- VIYQNHNK (8aa)
- IIQVVYIHSNNITK (14aa)
- LHSNNITK (8aa)
- GNISTEK (7aa)
- IGPGEPLELLCNVSGALPPPGR (22aa)
- INGTQICPN (9aa)
- DQSEDDRQHECLNVTQLLK (19aa)
- VFNATR (6aa)
- GEVFNATR (8aa)
- YFFNVSDEAAIIEK (14aa)
- NATDNISK (8aa)
- VQPFNVTQGK (10aa)
- AGIQAFFQVQECNK (14aa)
- KVSCPIMPCSNATVPDGECCPR (22aa)
- VSCPIMPCSNATVPDGECCPR (21aa)
- LNITCESSK (9aa)
- ALQAVYSMMSWPDDVPPEGWNR (22aa)
- NNLTTYK (7aa)
- ANYTILK (7aa)
- GTAGNAIMDGASQIMGENR (19aa)
- YRGTAGNALMDGASQLMGENR (21aa)
- ENITAPGSDSAVFFEQGTTR (20aa)
- TMVFPVMYLNESVHIDK (17aa)
- AVNITSENLIDDVVSLIR (18aa)
- CLLYPPWDKNFTENDLLVR (19aa)
- NFTENDLLVR (10aa)
- DECWCPANSTGK (12aa)
- NYTDCTSEGR (10aa)
- CGIVPVIAENYNK (13aa)
- CGLVPVLAENYNK (13aa)
- IFNIHSGNGSLYTSKPLDR (19aa)
- AIPQPQNVTSIIGCTH (16aa)
- ILDQACGTDNQTYASSCHLFATK (23aa)
- GKANSTGTLVITNPTR (16aa)
- RTAGWNIPMGLLFNQTGSCKF (21aa)
- KWNNTGCQALPSQDEGPSKA (20aa)
- CEGPGVPTVTVHNTTDKRR (19aa)
- CEGPGVPTVTVHNTTDK (17aa)
- CEGPGVPTVTVHNTTDKR (18aa)
- PPANSTMGSK (10aa)
- DQCIVDDITYNVNDTFHK (18aa)
- SCVAVTSAQPQNMSR (15aa)
- CQEAINATCK (10aa)
- RHEEGHMINCTCFGQGR (17aa)
- HEEGHMLNCTCFGQGR (16aa)
- TYENGSSVEYR (11aa)
- QVLSYGQNLSFSFR (14aa)
- EVNDTLLVNELK (12aa)
- TTIVDNNTWNNSHIAIVGK (19aa)
- NNSNNFDLNR (10aa)
- QQQHIFGSNVTDCSGNFCIFR (21aa)
- TLNCSGAHVK (10aa)
- INNTHALVSLLQNLNK (16aa)
- ISKINNTHALVSLLQNLNK (19aa)
- GPFEKNCSVQCAGMTLQTIPLK (22aa)
- KVEVEAVNATAVK (13aa)
- GEGNETNNMVITWKPLR (17aa)
- QLSCVANQNGSQADCELGNPFK (22aa)
- NMTLFSDLVAEK (12aa)
- NVTAQICIDK (10aa)
- ISAIDNIINHSSMFIK (16aa)
- QMVENFSPNQTK (12aa)
- ISEENETTCYMGK (13aa)
- VVNSTTGPGEHIR (13aa)
- CDSGFALDSEERNCTDIDECR (21aa)
- VVNSTTGTGEHIR (13aa)
- SPYEMFGDEEVMCLNGNWTEPPQCK (25aa)
- NGTHWFVT (8aa)
- ITTTPTNGQQGNSIEEVVHADQSSCTFDNISPGIEYNVSVYTVK (44aa)
- NISQDLEK (8aa)
- NTSPEGWK (8aa)
- AWGTPCEMCPAVNTSEYK (18aa)
- AFINGTGVETVVSADIPNAHGIAVDWVSR (29aa)
- NLQVYNATSNSLTVK (15aa)
- DACGNGTCR (9aa)
- THANGSIK (8aa)
- VDIPQQPMGIIAVANDTNSCEISPCR (26aa)
- MIEAYNITEK (10aa)
- NALQINNTAVGHAL (14aa)
- EAGNITTDGYEIIGK (15aa)
- NASLALSASIGR (12aa)
- QNLTVTDR (8aa)
- TCVSNCTASQFVCK (14aa)
- SLTQGSLIVGDLAPVNGTSQGK (22aa)
- GVTHLNISGLK (11aa)
- LNGTDPIVAADSK (13aa)
- FGHSPLINLTGGLSHASDVVLYHQHK (26aa)
Mass spectrometry observed peptide
-
- Free / Lactose
(avg mass : 1949.7927)
- Milk (UBERON_0001913)
-
- Free / Lactose
(avg mass : 1949.7927)
- Milk (UBERON_0001913)
-
- Free / Lactose
(avg mass : 1949.7927)
- Milk (UBERON_0001913)
-
- Free / Lactose
(avg mass : 1949.7927)
- Milk (UBERON_0001913)
- Increasing the Coverage of a Mass Spectral Library of Milk Oligosaccharides Using a Hybrid-Search-Based Bootstrapping Method and Milks from a Wide Variety of Mammals (2020 - Concepcion Africano Remoroza, Yuxue Liang, Tytus D. Mak, Yuri Mirokhin, Sergey L. Sheetlin, Xiaoyu Yang, Joice V. San Andres, Michael L. Power, and Stephen E. Stein) / Status : Reviewed
- Human milk oligosaccharides as essential tools for basic and application studies on galectins (2018 - Tadasu Urashima, Jun Hirabayashi, Sachiko Sato, Akira Kobata) / Status : Reviewed
-
- Free / Lactose
(avg mass : 1949.7927)
- Milk (UBERON_0001913)
- Increasing the Coverage of a Mass Spectral Library of Milk Oligosaccharides Using a Hybrid-Search-Based Bootstrapping Method and Milks from a Wide Variety of Mammals (2020 - Concepcion Africano Remoroza, Yuxue Liang, Tytus D. Mak, Yuri Mirokhin, Sergey L. Sheetlin, Xiaoyu Yang, Joice V. San Andres, Michael L. Power, and Stephen E. Stein) / Status : Reviewed
- Human milk oligosaccharides as essential tools for basic and application studies on galectins (2018 - Tadasu Urashima, Jun Hirabayashi, Sachiko Sato, Akira Kobata) / Status : Reviewed
-
- Free / Lactose
(avg mass : 1949.7927)
- Milk (UBERON_0001913)
-
- Free / Lactose
(avg mass : 1949.7927)
- Milk (UBERON_0001913)
-
- Free / Lactose
(avg mass : 1949.7927)
- Milk (UBERON_0001913)
-
- N-Linked / Complex
(avg mass : 1949.7927)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 1949.7927)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 1949.7927)
- Seminal Fluid (UBERON_0006530)
- Major seminal plasma glycoprotein psp-i / Sus scrofa
- Major seminal plasma glycoprotein psp-ii / Sus scrofa
-
- N-Linked / Complex
(avg mass : 1949.7927)
- Blood Plasma (UBERON_0001969)
- Brain (UBERON_0000955)
- Glomerular Basement Membrane (UBERON_0005777)
- J558L (CVCL_3949)
- Myeloma (DOID:0070004)
- Structural study of the sugar chains of porcine factor VIII--tissue- and species-specific glycosylation of factor VIII. (1993 - Hironaka T, Furukawa K, Esmon P, Yokota T, Brown J, Sawada S, Fournel M, Kato M, Minaga T, Kobata A) / Status : Reviewed
- Control of IgG/Fc glycosylation: a comparison of oligosaccharides from chimeric human/mouse and mouse subclass immunoglobulin Gs. (1993 - Lund J, Takahashi N, Nakagawa H, Goodall M, Bentley T, Hindley S, Tyler R, Jefferis R) / Status : Reviewed
- Bovine glomerular basement membrane. Location and structure of the asparagine-linked oligosaccharide units and their potential role in the assembly of the 7 S collagen IV tetramer. (1991 - Langeveld J, Noelken M, Hrd K, Todd P, Vliegenthart J, Rouse J, Hudson B) / Status : Reviewed
- The structure of the asparagine-linked sugar chains of bovine brain ribonuclease. (1990 - Katoh H, Ohgi K, Irie M, Endo T, Kobata A) / Status : Reviewed
- A protein structural change in aglycosylated IgG3 correlates with loss of huFc gamma R1 and huFc gamma R111 binding and/or activation. (1990 - Lund J, Tanaka T, Takahashi N, Sarmay G, Arata Y, Jefferis R) / Status : Reviewed
-
Collagen alpha-1(IV) chain / Bos taurus
- Undefined site
-
Collagen alpha-2 (IV) chain / Bos taurus
- Undefined site
- Ribonuclease, brain / Bos taurus
-
Immunoglobulin gamma-2 (anti-nip antibody) / Hybrid - homo sapiens/mus musculus
- Undefined site
-
Immunoglobulin gamma-2b (anti-nip antibody) / Hybrid - homo sapiens/mus musculus
- Undefined site
-
Immunoglobulin gamma-3 (anti-nip antibody) / Hybrid - homo sapiens/mus musculus
- Undefined site
-
Immunoglobulin gamma-3b (anti-nip antibody) / Hybrid - homo sapiens/mus musculus
- Undefined site
-
Coagulation factor VIII / Sus scrofa
- Undefined site
-
- N-Linked / Complex
(avg mass : 1949.7927)
- Ascitic fluid (UBERON_0007795) EL4 (CVCL_0255)
- BW5147 (CVCL_3896) T-Lymphocyte (CL_0000084)
- WEHI-231 (CVCL_0577) B-Lymphocyte (CL_0000236)
- B-Lymphocyte (CL_0000236)
- T-Lymphocyte (CL_0000084)
- Plasma Membrane (GO_0005886)
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein from Ascitic fluid / Mus musculus
- Undefined site
-
- N-Linked / Complex
(avg mass : 1949.7927)
- N-linked oligosaccharide structures in the diamine oxidase from porcine kidney. (2000 - Huang Y, Mechref Y, Novotny M) / Status : Reviewed
- The asparagine-linked sugar chains of the glycoproteins in rat erythrocyte plasma membrane--fractionation of oligosaccharides liberated by hydrazinolysis and structural studies of the neutral oligosaccharides. (1982 - Matsumoto A, Yoshima H, Maeda S, Shiraishi N, Kobata A) / Status : Reviewed
-
Uncharacterized protein / Rattus norvegicus
- Undefined site
-
Amiloride-sensitive amine oxidase / Sus scrofa
- Undefined site
-
- N-Linked / Complex
(avg mass : 1949.7927)
- Adipose-derived stem cells (ADSCs) (CL_0000136)
- Differentiated Adipose-derived stem cells (dADSCs) (CL_0000136)
-
- N-Linked / Complex
(avg mass : 1949.7927)
- Adipocytes (CL_0000136)
- Adipose-derived stem cells (ADSCs) (CL_0000136)
- Differentiated Adipose-derived stem cells (dADSCs) (CL_0000136)
-
- N-Linked / Hybrid
(avg mass : 1949.7927)
- Milk (UBERON_0001913)
- Lactotransferrin / Homo sapiens
- Polymeric immunoglobulin receptor / Homo sapiens
- RANLTNFPENGTFVVNIAQLSQDDSGRY (28aa)
- KQIGLYPVLVIDSSGYVNPNYTGRI (25aa)
- RTAGWNIPMGLLFNQTGSCKF (21aa)
- KWNNTGCQALPSQDEGPSKA (20aa)
-
- N-Linked / Hybrid
(avg mass : 1949.7927)
- Adipocytes (CL_0000136)
-
- N-Linked / Hybrid
(avg mass : 1949.7927)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- TQSLLIVNNATNVVIK (16aa)
- VFNATR (6aa)
-
- N-Linked / Hybrid
(avg mass : 1949.7927)
- Control/Healthy
- Hyper IgE syndrome (HIES, p.Glu340del) (DOID:0080545)
- Hyper IgE syndrome (HIES, p.Leu83Ser) (DOID:0080545)
-
- N-Linked / Hybrid
(avg mass : 1949.7927)
- Colon (UBERON_0001155)
- LS174T (CVCL_1384)
- Colon adenocarcinoma (DOID:234)
-
Carcinoembryonic antigen-related cell adhesion molecule 5 / Homo sapiens
- Undefined site
-
- N-Linked / Hybrid
(avg mass : 1949.7927)
- Colon (UBERON_0001155)
- LS174T (CVCL_1384)
- Colon adenocarcinoma (DOID:234)
-
Carcinoembryonic antigen-related cell adhesion molecule 5 / Homo sapiens
- Undefined site
-
- N-Linked / Hybrid
(avg mass : 1949.7927)
- Ascitic fluid (UBERON_0007795)
- Colon (UBERON_0001155)
- Liver (UBERON_0002107)
- LS174T (CVCL_1384)
- Colon adenocarcinoma (DOID:234)
-
Carcinoembryonic antigen-related cell adhesion molecule 5 / Homo sapiens
- Undefined site
-
- Hex:6 HexNAc:4 dHex:1 / N-Linked
(avg mass : 1949.7927)
- Blood Serum (UBERON_0001977)
- Brain (UBERON_0000955)
- Colon (UBERON_0001155)
- Mammary Gland (UBERON_0001911)
- Urine (UBERON_0001088)
- BTI-Tn-5B1-4 (CVCL_C190)
- CHO (CVCL_0213)
- FreeStyle 293-F (CVCL_D603)
- HEK293 (CVCL_0045)
- LS174T (CVCL_1384)
- N-Linked / Complex / Fuc(a1-2)[Gal(a1-3)]Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Fuc(a1-2)[Gal(a1-3)]Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Structure 9601
- N-Linked / Complex / Structure 9677
- N-Linked / Hybrid / Structure 9381
- N-Linked / Hybrid / Structure 9910
- N-Linked / Hybrid / Structure 10008
- N-Linked / Hybrid / Structure 10289
- N-Linked / Hybrid / Structure 10422
- N-Linked / Hybrid / Structure 10428
- N-Linked / Hybrid / Structure 10537
- Cancer, breast (DOID:1612)
- Colon adenocarcinoma (DOID:234)
- COVID-19 (DOID:0080600)
- Prostate cancer (DOID:10283)
- Carcinoembryonic antigen glycosylation (2021 - Kolarich D) / Status : Reviewed
- Structural and functional characterization of SARS-CoV-2 RBD domains produced in mammalian cells (2021 - Christoph Gstöttner, Tao Zhang, Anja Resemann, Sophia Ruben, Stuart Pengelley, Detlev Suckau, Tim Welsink, Manfred Wuhrer, Elena DomÃnguez-Vega) / Status : Reviewed
- Identification of 22 N-glycosites on spike glycoprotein of SARS-CoV-2 and accessible surface glycopeptide motifs: Implications for vaccination and antibody therapeutics (2020 - Dapeng Zhou, Xiaoxu Tian, Ruibing Qi, Chao Peng, Wen Zhang) / Status : Reviewed
- Site-specific glycan analysis of the SARS-CoV-2 spike (2020 - Yasunori Watanabe, Joel D. Allen, Daniel Wrapp, Jason S. McLellan, Max Crispin) / Status : Unreviewed
- Capturing site-specific heterogeneity with large-scale N-glycoproteome analysis (2019 - Nicholas M. Riley, Alexander S. Hebert, Michael S. Westphall & Joshua J. Coon ) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Efficient and accurate glycopeptide identification pipeline for high-throughput site-specific N-glycosylation analysis (2014 - Liu M, Zhang Y, Chen Y, Yan G, Shen C, Cao J, Zhou X, Liu X, Zhang L, Shen H, Lu H, He F, Yang P) / Status : Reviewed
- Alpha-1-antichymotrypsin / Homo sapiens
- Alpha-1-antitrypsin / Homo sapiens
- Alpha-2-HS-glycoprotein / Homo sapiens
- Alpha-2-macroglobulin receptor-associated protein / Homo sapiens
- Anoctamin-6 / Homo sapiens
- Antithrombin-III / Homo sapiens
- Apolipoprotein D / Homo sapiens
- Basement membrane-specific heparan sulfate proteoglycan core protein / Homo sapiens
- Beta-2-glycoprotein 1 / Homo sapiens
- Biglycan / Homo sapiens
- Calbindin / Homo sapiens
-
Carcinoembryonic antigen-related cell adhesion molecule 5 / Homo sapiens
- Undefined site
- CD276 antigen / Homo sapiens
- CD59 glycoprotein / Homo sapiens
- Ceruloplasmin / Homo sapiens
- CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 / Homo sapiens
- Coagulation factor XIII B chain / Homo sapiens
- Collagen alpha-1(VI) chain / Homo sapiens
- Collagen alpha-1(XII) chain / Homo sapiens
- Collagen alpha-2(VI) chain / Homo sapiens
- Collagen alpha-3(VI) chain / Homo sapiens
- Complement component C9 / Homo sapiens
- Complement factor b / Homo sapiens
- Complement factor h / Homo sapiens
- Complement factor H-related protein 1 / Homo sapiens
- Decorin / Homo sapiens
- Desmocollin-2 / Homo sapiens
- Dipeptidyl peptidase 1 / Homo sapiens
- Disintegrin and metalloproteinase domain-containing protein 17 / Homo sapiens
- DNA-dependent protein kinase catalytic subunit / Homo sapiens
- Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B / Homo sapiens
- Fibrillin-1 / Homo sapiens
- Fibrinogen beta chain / Homo sapiens
- Fibrinogen gamma chain / Homo sapiens
- Fibromodulin / Homo sapiens
- Fibronectin / Homo sapiens
- Haptoglobin / Homo sapiens
- Hemopexin / Homo sapiens
- Histidine-rich glycoprotein / Homo sapiens
- Hypoxia up-regulated protein 1 / Homo sapiens
- Immunoglobulin heavy constant alpha 1 / Homo sapiens
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- Immunoglobulin heavy constant gamma 1 / Homo sapiens
- Immunoglobulin heavy constant mu / Homo sapiens
- Immunoglobulin J chain / Homo sapiens
- Integrin alpha-1 / Homo sapiens
- Integrin alpha-2 / Homo sapiens
- Integrin alpha-6 / Homo sapiens
- Inter-alpha-trypsin inhibitor heavy chain H3 / Homo sapiens
- Interleukin-1 receptor accessory protein / Homo sapiens
- Laminin subunit alpha-4 / Homo sapiens
- Laminin subunit alpha-5 / Homo sapiens
- Laminin subunit gamma-1 / Homo sapiens
- Latent-transforming growth factor beta-binding protein 2 / Homo sapiens
- Lysosome membrane protein 2 / Homo sapiens
- Lysosome-associated membrane glycoprotein 1 / Homo sapiens
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens
- Mannan-binding lectin serine protease 1 / Homo sapiens
- Mimecan / Homo sapiens
- Niemann-Pick C1 protein / Homo sapiens
- Olfactomedin-like protein 3 / Homo sapiens
- Peptidyl-prolyl cis-trans isomerase FKBP10 / Homo sapiens
- Periostin / Homo sapiens
- Plexin-B2 / Homo sapiens
- Polymeric immunoglobulin receptor / Homo sapiens
- Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 / Homo sapiens
- Prolactin-inducible protein / Homo sapiens
- Prolargin / Homo sapiens
- Prolow-density lipoprotein receptor-related protein 1 / Homo sapiens
- Prostaglandin-h2 d-isomerase / Homo sapiens
- Protein AMBP / Homo sapiens
- Protein disulfide-isomerase A2 / Homo sapiens
- Prothrombin / Homo sapiens
- Reticulocalbin-1 / Homo sapiens
- Secretogranin-3 / Homo sapiens
- Serotransferrin / Homo sapiens
- Sparc / Homo sapiens
- Tetraspanin-3 / Homo sapiens
- Thrombospondin-1 / Homo sapiens
- Thrombospondin-2 / Homo sapiens
- Translocon-associated protein subunit alpha / Homo sapiens
- Uromodulin / Homo sapiens
- Vitronectin / Homo sapiens
- Zinc-alpha-2-glycoprotein / Homo sapiens
- Cadherin-10 / Mus musculus
- Cadherin-13 / Mus musculus
- Carbonic anhydrase-related protein 10 / Mus musculus
- Carboxypeptidase D / Mus musculus
- Carboxypeptidase M / Mus musculus
- Cell adhesion molecule 4 / Mus musculus
- Contactin-1 / Mus musculus
- Dipeptidyl aminopeptidase-like protein 6 / Mus musculus
- Gamma-aminobutyric acid receptor subunit beta-2 / Mus musculus
- Golgi apparatus protein 1 / Mus musculus
- Heparan sulfate 2-O-sulfotransferase 1 / Mus musculus
- Immunoglobulin superfamily member 8 / Mus musculus
- Integrin beta-2 / Mus musculus
- Isoform 14 of Disintegrin and metalloproteinase domain-containing protein 22 / Mus musculus
- Isoform 2 of Cell adhesion molecule 2 / Mus musculus
- Leukocyte surface antigen CD47 / Mus musculus
- Myelin-oligodendrocyte glycoprotein / Mus musculus
- Nectin-1 / Mus musculus
- Neural cell adhesion molecule L1 / Mus musculus
- Neurofascin / Mus musculus
- Neuroplastin / Mus musculus
- Prolow-density lipoprotein receptor-related protein 1 / Mus musculus
- Receptor-type tyrosine-protein phosphatase delta / Mus musculus
- Signal-regulatory protein alpha / Mus musculus
- Sodium/potassium-transporting ATPase subunit beta-2 / Mus musculus
- SPARC / Mus musculus
- SPARC-like protein 1 / Mus musculus
- Tetraspanin-2 / Mus musculus
- Thy-1 membrane glycoprotein / Mus musculus
- Zinc transporter ZIP10 / Mus musculus
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (FreeStyle 293-F) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- LELNLTDSENATCLYAK (17aa)
- SVAQNYSSITHLHSIGK (17aa)
- VKGSQGQFPLTQNVTVVEGGTAILTCR (27aa)
- GSQGQFPLTQNVTVVEGGTAILTCR (25aa)
- TAVNCSSDFDACLITK (16aa)
- VVRPDSEIGERPPEDNQSFQYDHEAFIGK (29aa)
- ISPGKNATGMEVGWYR (16aa)
- FSNVTWF (7aa)
- CSDGWSFDATTLDDNGTMLFFK (22aa)
- CIQANYSIMENGK (13aa)
- QTLFFNGTR (9aa)
- SVVAPATDGGLNLTSTFLR (19aa)
- DLQSLEDILHQVENK (15aa)
- FNQTMQPIITAQNAIIEDDTYR (22aa)
- TAFITNFTLTIDGVTYPGNVK (21aa)
- IRNVSDTTKR (10aa)
- IRNVSDTTK (9aa)
- ADGTVNQIEGEATPVNLTEPAK (22aa)
- TAIFPDIIAQGNASIR (16aa)
- LSYNVIPLNLTLDNR (15aa)
- TFYWDFYTNR (10aa)
- ADTHDEIIEGINFNITEIPEAQIHEGFQEIIR (32aa)
- YHVLHINTTK (10aa)
- DIVEYYNDSNGSHVIQGR (18aa)
- DAMVGNYTCEVTELSR (16aa)
- VCSNDNKTFDSSCHFFATK (19aa)
- VCSNDNK (7aa)
- LDKEHLVNISGGPMTYSHR (19aa)
- NTTYCSK (7aa)
- DEGDYFCELQVSGANPMSSNK (21aa)
- IVNNATNVVIK (11aa)
- VIDFNCTTSSVSSAIANTK (19aa)
- TINQSSDEIQISMGNAMFVK (20aa)
- FGCEIENNR (9aa)
- LSLHRPALEDLLLGSEANLTCTLTGLR (27aa)
- YPQDYQFYIQNFTAIPINTVVPPQR (25aa)
- ARGNGTLITFHSAFQCCGK (19aa)
- ACQFNR (6aa)
- VCQDCPIIAPINDTR (15aa)
- VCQDCPLLAPLNDTR (15aa)
- LNLTTDPK (8aa)
- IYIDHNNITR (10aa)
- NQSVPISCCR (10aa)
- GIPDQKVNFTCK (12aa)
- VNFTCK (6aa)
- NGSLFAFR (8aa)
- AALAAFNAQNNGSNFQLEEISR (22aa)
- YHYNGTIIDGTSFDTSYSK (19aa)
- ACNATNWIEYMFNK (14aa)
- QIGLYPVLVIDSSGYVNPNYTGR (23aa)
- SWPAVGNCSSAIR (13aa)
- SWPAVGNCSSAL (12aa)
- SLTFNETYQDISELVYGAK (19aa)
- NASNMEYR (8aa)
- KNASNMEYR (9aa)
- EQINITIDHR (10aa)
- LKGEAEYQEIRNPNGTVTVISR (22aa)
- NPNGTVTVISR (11aa)
- IADTNITSIPQGIPPSITEIHIDGNK (26aa)
- KLNNLTFLYLDHNALESVPLNLPESLR (27aa)
- NTTGFK (6aa)
- CNTAAPMWLNGTHPSSDEGIVSR (23aa)
- VVIHPNYSQVDIGIIK (16aa)
- FEDGVLDPDYPRNISDGFDGIPDNVDAALALPAHSYSGR (39aa)
- FHLANR (6aa)
- CNMINGTDGDSFHPIITK (18aa)
- YFYNGTSMACETFQYGGCMGNGNNFVTEK (29aa)
- IGNWSAMPSCK (11aa)
- IININPNK (8aa)
- VIDLWDLAQSANLTDK (16aa)
- MIENGSISFIPTIR (14aa)
- YIGNATAIFFIPDEGK (16aa)
- YLGNATAIFFLPDEGK (16aa)
- LNSSTIK (7aa)
- IITNNSQTPIISPQEVVSCSQYAQGCEGGFPYIIAGK (37aa)
- VIYQNHNK (8aa)
- IIQVVYIHSNNITK (14aa)
- LHSNNITK (8aa)
- GNISTEK (7aa)
- IGPGEPLELLCNVSGALPPPGR (22aa)
- INGTQICPN (9aa)
- DQSEDDRQHECLNVTQLLK (19aa)
- GEVFNATR (8aa)
- YFFNVSDEAAIIEK (14aa)
- NATDNISK (8aa)
- VQPFNVTQGK (10aa)
- AGIQAFFQVQECNK (14aa)
- KVSCPIMPCSNATVPDGECCPR (22aa)
- VSCPIMPCSNATVPDGECCPR (21aa)
- LNITCESSK (9aa)
- ALQAVYSMMSWPDDVPPEGWNR (22aa)
- NNLTTYK (7aa)
- ANYTILK (7aa)
- GTAGNAIMDGASQIMGENR (19aa)
- YRGTAGNALMDGASQLMGENR (21aa)
- ENITAPGSDSAVFFEQGTTR (20aa)
- TMVFPVMYLNESVHIDK (17aa)
- AVNITSENLIDDVVSLIR (18aa)
- CLLYPPWDKNFTENDLLVR (19aa)
- NFTENDLLVR (10aa)
- DECWCPANSTGK (12aa)
- NYTDCTSEGR (10aa)
- CGIVPVIAENYNK (13aa)
- CGLVPVLAENYNK (13aa)
- IFNIHSGNGSLYTSKPLDR (19aa)
- AIPQPQNVTSIIGCTH (16aa)
- ILDQACGTDNQTYASSCHLFATK (23aa)
- GKANSTGTLVITNPTR (16aa)
- CEGPGVPTVTVHNTTDKRR (19aa)
- CEGPGVPTVTVHNTTDK (17aa)
- CEGPGVPTVTVHNTTDKR (18aa)
- PPANSTMGSK (10aa)
- DQCIVDDITYNVNDTFHK (18aa)
- SCVAVTSAQPQNMSR (15aa)
- CQEAINATCK (10aa)
- RHEEGHMINCTCFGQGR (17aa)
- HEEGHMLNCTCFGQGR (16aa)
- TYENGSSVEYR (11aa)
- QVLSYGQNLSFSFR (14aa)
- EVNDTLLVNELK (12aa)
- TTIVDNNTWNNSHIAIVGK (19aa)
- NNSNNFDLNR (10aa)
- QQQHIFGSNVTDCSGNFCIFR (21aa)
- TLNCSGAHVK (10aa)
- INNTHALVSLLQNLNK (16aa)
- ISKINNTHALVSLLQNLNK (19aa)
- GPFEKNCSVQCAGMTLQTIPLK (22aa)
- KVEVEAVNATAVK (13aa)
- GEGNETNNMVITWKPLR (17aa)
- QLSCVANQNGSQADCELGNPFK (22aa)
- NMTLFSDLVAEK (12aa)
- NVTAQICIDK (10aa)
- ISAIDNIINHSSMFIK (16aa)
- QMVENFSPNQTK (12aa)
- ISEENETTCYMGK (13aa)
- VVNSTTGPGEHIR (13aa)
- CDSGFALDSEERNCTDIDECR (21aa)
- VVNSTTGTGEHIR (13aa)
- SPYEMFGDEEVMCLNGNWTEPPQCK (25aa)
- NGTHWFVT (8aa)
- ITTTPTNGQQGNSIEEVVHADQSSCTFDNISPGIEYNVSVYTVK (44aa)
- NISQDLEK (8aa)
- NTSPEGWK (8aa)
- AWGTPCEMCPAVNTSEYK (18aa)
- AFINGTGVETVVSADIPNAHGIAVDWVSR (29aa)
- NLQVYNATSNSLTVK (15aa)
- DACGNGTCR (9aa)
- THANGSIK (8aa)
- VDIPQQPMGIIAVANDTNSCEISPCR (26aa)
- MIEAYNITEK (10aa)
- NALQINNTAVGHAL (14aa)
- EAGNITTDGYEIIGK (15aa)
- NASLALSASIGR (12aa)
- QNLTVTDR (8aa)
- TCVSNCTASQFVCK (14aa)
- SLTQGSLIVGDLAPVNGTSQGK (22aa)
- GVTHLNISGLK (11aa)
- LNGTDPIVAADSK (13aa)
- FGHSPLINLTGGLSHASDVVLYHQHK (26aa)
Source
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:4 dHex:1 / N-Linked
(avg mass : 1949.7927)
Source
Disease
Reported glycosite
- N-Linked / Hybrid
(avg mass : 1949.7927)
Source
Disease
Reported glycosite
- N-Linked / Hybrid
(avg mass : 1949.7927)
Source
Disease
Reported glycosite
- N-Linked / Hybrid
(avg mass : 1949.7927)
Disease
Reported glycosite
- N-Linked / Hybrid
(avg mass : 1949.7927)
Source
Disease
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Hybrid
(avg mass : 1949.7927)
Source
Reported glycosite
- N-Linked / Hybrid
(avg mass : 1949.7927)
Source
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Hybrid
(avg mass : 1949.7927)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 1949.7927)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 1949.7927)
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 1949.7927)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 1949.7927)
Source
Disease
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 1949.7927)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 1949.7927)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 1949.7927)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 1949.7927)
Source
Reported glycosite
- Free / Lactose
(avg mass : 1949.7927)
Source
Reported glycosite
- Free / Lactose
(avg mass : 1949.7927)
Source
Reported glycosite
- Free / Lactose
(avg mass : 1949.7927)
Source
Reference
Reported glycosite
- Free / Lactose
(avg mass : 1949.7927)
Source
Reference
Reported glycosite
- Free / Lactose
(avg mass : 1949.7927)
Source
Reported glycosite
- Free / Lactose
(avg mass : 1949.7927)
Source
Reported glycosite
- Free / Lactose
(avg mass : 1949.7927)
Source
Reported glycosite
- Free / Lactose
(avg mass : 1949.7927)